Xconomy Boston

Exact Science Secures $8,200,000 New Financing Round

  • Feed Type
  • Date
    6/12/2009
  • Company Name
    Exact Science
  • Mailing Address
    Undisclosed Marlborough, MA 01752
  • Company Description
    The company, which has developed a molecular screening test for colorectal cancer, also said it has licensed technology developed by cancer researcher David Ahlquist at the Mayo Clinic covering aspects of sample processing and data analysis related to DNA screening for the disease.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,200,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.